We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Ovoca Bio Plc | LSE:OVB | London | Ordinary Share | IE00B4XVDC01 | EUR0.125 (CDI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.60 | 1.50 | 1.70 | 1.60 | 1.60 | 1.60 | 238 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 1.03M | -4.7M | -0.0576 | -0.28 | 1.31M |
Ovoca Bio plc
("Ovoca" or the "Company")
Holding(s) in Company
Dublin, Ireland, October 11, 2024 - Ovoca Bio, a biopharmaceutical company with a focus on women's health, has received notification from Mr. Timothy McCutcheon that, as of 9 October 2014, he holds an interest in 19,506,203 Ordinary Shares of nominal value €0.125 each, which represents approximately 22.05% of the Company's issued share capital. This percentage shareholding is based on the latest shares in issue figure of 88,458,806 ordinary shares of nominal value €0.125 each following the Company's recent sale of ordinary shares from treasury, as announced on 9 October 2024.
End
For further information:
Ovoca Bio plc
Tim McCutcheon (Chief Executive Officer)
Tel +353 1 661 9819
info@ovocabio.com
Davy (Nominated Adviser, Euronext Growth Listing Sponsor and Broker)
Ivan Murphy / Daragh O'Reilly
Tel: +353 1 679 6363
1 Year Ovoca Bio Chart |
1 Month Ovoca Bio Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions